REGENEREX PHARMA, INC.

Regenerex Pharma, Inc. announced the termination of its Chief Financial Officer, Kenneth Perry, for Cause, effective May 2, 2026. This decision followed an administrative suspension initiated on March 31, 2026, and a comprehensive review by the Governance and Nominating Committee, which found a material and continuing breach of his Employment Agreement. Concurrently, Don E. Ray was appointed as Interim CFO on April 1, 2026, for an initial 90-day term.